The Predictive Value of the EULAR-Defined Clinically Suspected Arthralgia for the Development of Rheumatoid Arthritis: A Prospective Longitudinal Study

Objective: To assess the predictive accuracy of the EULAR definition of clinically suspected arthralgia (CSA) for progression to rheumatoid arthritis (RA) in patients presenting with arthralgia without arthritis. Methods: This prospective study recruited 100 patients with arthralgia but no clinical...

Full description

Saved in:
Bibliographic Details
Published inJournal of clinical rheumatology and immunology (Online) Vol. 24; no. 1; pp. 34 - 40
Main Authors Tam, Cheuk Yin, Chan, Pak Ho, Cheng, Minerva Yuk Yee, Lau, Adrian Ka Chun, Tam, Kwan Kin, Cheng, Tsz Ho, So, Ho
Format Journal Article
LanguageEnglish
Published World Scientific Publishing 01.07.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Objective: To assess the predictive accuracy of the EULAR definition of clinically suspected arthralgia (CSA) for progression to rheumatoid arthritis (RA) in patients presenting with arthralgia without arthritis. Methods: This prospective study recruited 100 patients with arthralgia but no clinical arthritis. Patients were evaluated at baseline and followed up every 6 months for 2 years. The association of the presence of [Formula: see text] and [Formula: see text] out of seven CSA parameters at baseline with RA development was investigated. The association of individual CSA parameters with RA development was also evaluated. Results: Twenty-one of 100 patients (21%) developed RA. The proportion of patients meeting [Formula: see text] CSA criteria was higher in those who developed RA (66.7%) compared to those who did not (39.2%, [Formula: see text]). Similarly, a higher proportion of patients who developed RA met [Formula: see text] CSA criteria (47.6%) compared to those who did not (20.3%, [Formula: see text]). The sensitivity and specificity of [Formula: see text] CSA parameters were 71.4% and 69.6%, and for [Formula: see text] CSA parameters were 42.9% and 87.3%, respectively. “Symptom duration [Formula: see text] year” and “difficulty holding a fist” were significantly associated with RA development. A simplified criteria using these two items provided a similar area under receiver operating characteristic (ROC) curve (0.747 vs. 0.676) compared to the original criteria. Conclusion: Meeting EULAR CSA criteria was significantly associated with progression to RA in patients with arthralgia. Symptom duration [Formula: see text] year and difficulty holding a fist were the most predictive individual parameters. Continuous monitoring using the CSA criteria, and probably a simplified version, could help identify high-risk individuals for RA development.
ISSN:2661-3417
2661-3425
DOI:10.1142/S2661341724500032